مقابله با بیماری عفونی

داروسازی Arsanis:رویکرد مقابله با بیماری های عفونی

Summary The company is developing monoclonal antibodies directed against bacteria and viruses. The key R&D program is ASN100, which is directed against 6 cytotoxins critical…